Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis
- PMID: 19919762
Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis
Abstract
Mathematical models predict that the future of the multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) epidemic will depend to a large extent on the transmission efficiency or relative fitness of drug-resistant Mycobacterium tuberculosis compared to drug-susceptible strains. Molecular epidemiological studies comparing the spread of drug-resistant to that of drug-susceptible strains have yielded conflicting results: MDR strains can be up to 10 times more or 10 times less transmissible than pan-susceptible strains. Experimental work performed with model organisms has highlighted a level of complexity in the biology of bacterial drug resistance that is generally not considered during standard epidemiological studies of TB transmission. Recent experimental studies in M. tuberculosis indicate that drug resistance in this organism could be equally complex. For example, the relative fitness of drug-resistant strains of M. tuberculosis can be influenced by the specific drug resistance-conferring mutation and strain genetic background. Furthermore, compensatory evolution, which has been shown to mitigate the fitness defects associated with drug resistance in other bacteria, could be an important factor in the emergence and spread of drug-resistant M. tuberculosis. However, much more work is needed to understand the detailed molecular mechanisms and evolutionary forces that drive drug resistance in this pathogen. Such increased knowledge will allow for better epidemiological predictions and assist in the development of new tools and strategies to fight drug-resistant TB.
Similar articles
-
Mechanisms of drug resistance in Mycobacterium tuberculosis.Int J Tuberc Lung Dis. 2009 Nov;13(11):1320-30. Int J Tuberc Lung Dis. 2009. PMID: 19861002 Review.
-
Molecular epidemiology of drug resistant Mycobacterium tuberculosis in Africa: a systematic review.BMC Infect Dis. 2020 May 13;20(1):344. doi: 10.1186/s12879-020-05031-5. BMC Infect Dis. 2020. PMID: 32404119 Free PMC article.
-
The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis.Trends Genet. 2013 Mar;29(3):160-9. doi: 10.1016/j.tig.2012.11.005. Epub 2012 Dec 13. Trends Genet. 2013. PMID: 23245857 Free PMC article. Review.
-
Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.Tuberculosis (Edinb). 2016 Mar;97:18-25. doi: 10.1016/j.tube.2015.11.007. Epub 2015 Dec 23. Tuberculosis (Edinb). 2016. PMID: 26980491
-
First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil.Infect Genet Evol. 2020 Mar;78:104127. doi: 10.1016/j.meegid.2019.104127. Epub 2019 Nov 26. Infect Genet Evol. 2020. PMID: 31783187
Cited by
-
Multidrug-resistant tuberculosis clusters and transmission in Taiwan: a population-based cohort study.Front Microbiol. 2024 Sep 18;15:1439532. doi: 10.3389/fmicb.2024.1439532. eCollection 2024. Front Microbiol. 2024. PMID: 39360329 Free PMC article.
-
Mathematical models of drug-resistant tuberculosis lack bacterial heterogeneity: A systematic review.PLoS Pathog. 2024 Apr 10;20(4):e1011574. doi: 10.1371/journal.ppat.1011574. eCollection 2024 Apr. PLoS Pathog. 2024. PMID: 38598556 Free PMC article.
-
The recent rapid expansion of multidrug resistant Ural lineage Mycobacterium tuberculosis in Moldova.Nat Commun. 2024 Apr 5;15(1):2962. doi: 10.1038/s41467-024-47282-9. Nat Commun. 2024. PMID: 38580642 Free PMC article.
-
Borderline rpoB mutations transmit at the same rate as common rpoB mutations in a tuberculosis cohort in Bangladesh.Microb Genom. 2023 Sep;9(9):001109. doi: 10.1099/mgen.0.001109. Microb Genom. 2023. PMID: 37750750 Free PMC article.
-
The Impact of Preventive Treatment for Multidrug- and Rifampin-Resistant Tuberculosis Exceeds Trial-Based Estimates.Clin Infect Dis. 2024 Jan 25;78(1):133-143. doi: 10.1093/cid/ciad557. Clin Infect Dis. 2024. PMID: 37724763 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources